Together, these findings support the potential of targeting centrosome amplification as an alternative therapeutic approach for aggressive ALDH+ cancers failing first-line therapeutics.<h4>Significance</h4>This study identifies MEAP as the first selective vulnerability of ALDH+ ATC stem cells, their dysfunctional supernumerary centrosomes. Here, LDHA is linked to cancer.